Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose fenfluramine add-on therapy in myoclonic astatic epilepsy (Doose syndrome)
DRKS00016679Phase 2Completed
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of fenfluramine in myoclonic astatic epilepsy (MAE) and generalized epilepsy, sponsored by Universitätsklinikum Schleswig-Holstein. Started Nov 2019; status: completed.
02
Drugs
fenfluramine
03
Conditions
myoclonic astatic epilepsy (MAE)generalized epilepsy
Beyond the preview
Go deeper on DRKS00016679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00016679.